Eighteenfiftynine Company
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Founded Date:
2019-01-01
Total Funding:
52200000.0
Headquarters:
San Diego, California, United States
Last Funding Date:
2022-02-07
Investors Number:
4.0
Last Funding Type:
Series A
Industry:
Early Drug Development